Published in Biochem J on November 15, 1992
TGN38 is maintained in the trans-Golgi network by a tyrosine-containing motif in the cytoplasmic domain. EMBO J (1993) 2.79
Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochem J (1993) 1.37
Sulphydryl agents modulate insulin- and epidermal growth factor (EGF)-receptor kinase via reaction with intracellular receptor domains: differential effects on basal versus activated receptors. Biochem J (1993) 0.94
Insulin stimulates movement of sorting nexin 9 between cellular compartments: a putative role mediating cell surface receptor expression and insulin action. Biochem J (2003) 0.85
Cysteine-524 is not the only residue involved in the formation of disulphide-bonded dimers of the insulin receptor. Biochem J (1994) 0.80
Ligand-Binding Affinity at the Insulin Receptor Isoform-A and Subsequent IR-A Tyrosine Phosphorylation Kinetics are Important Determinants of Mitogenic Biological Outcomes. Front Endocrinol (Lausanne) (2015) 0.76
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
"Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem (1981) 71.15
A simple method for the preparation of 32-P-labelled adenosine triphosphate of high specific activity. Biochem J (1964) 41.13
Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol (1981) 14.45
Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature (1985) 13.79
Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell (1986) 8.87
General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci U S A (1985) 8.77
The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell (1985) 7.45
Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J (1986) 6.62
Strategies for epitope analysis using peptide synthesis. J Immunol Methods (1987) 5.69
Monoclonal antibodies to receptors for insulin and somatomedin-C. J Biol Chem (1983) 2.53
One-step purification of mouse monoclonal antibodies from ascites fluid by hydroxylapatite chromatography. J Immunol Methods (1985) 1.93
Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor. Biochem J (1986) 1.87
Purification of insulin receptor with full binding activity. J Biol Chem (1983) 1.82
Insulin action is blocked by a monoclonal antibody that inhibits the insulin receptor kinase. Proc Natl Acad Sci U S A (1986) 1.80
Antibodies of predetermined specificity in biology and medicine. Adv Immunol (1984) 1.77
Synthetic peptides as antigens: pitfalls of conjugation methods. J Immunol Methods (1985) 1.76
Insulin receptors, receptor antibodies, and the mechanism of insulin action. Recent Prog Horm Res (1981) 1.68
Monoclonal antibodies to the human insulin receptor block insulin binding and inhibit insulin action. Proc Natl Acad Sci U S A (1982) 1.57
Autophosphorylation of the insulin receptor in vitro. Designation of phosphorylation sites and correlation with receptor kinase activation. J Biol Chem (1986) 1.54
Identification of insulin receptor tyrosine residues autophosphorylated in vitro. J Biol Chem (1987) 1.52
Affinity alteration of insulin receptor induced by a phorbol ester. Am J Physiol (1982) 1.51
Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells. Biochem J (1990) 1.49
Substrate phosphorylation catalyzed by the insulin receptor tyrosine kinase. Kinetic correlation to autophosphorylation of specific sites in the beta subunit. J Biol Chem (1989) 1.49
Inhibition of insulin receptor binding by phorbol esters. Eur J Biochem (1982) 1.49
Tryptic activation of the insulin receptor. Proteolytic truncation of the alpha-subunit releases the beta-subunit from inhibitory control. J Biol Chem (1988) 1.39
The chemistry and mechanism of antibody binding to protein antigens. Adv Immunol (1988) 1.37
Labeled antibodies and their use in the immunoradiometric assay. Methods Enzymol (1980) 1.32
Threonine 1336 of the human insulin receptor is a major target for phosphorylation by protein kinase C. Biochemistry (1990) 1.22
Topological mapping of complement component C9 by recombinant DNA techniques suggests a novel mechanism for its insertion into target membranes. EMBO J (1987) 1.18
Studies on the autophosphorylation of the insulin receptor from human placenta. Analysis of the sites phosphorylated by two-dimensional peptide mapping. Biochem J (1988) 1.16
Monoclonal antibodies to the human insulin receptor that activate glucose transport but not insulin receptor kinase activity. Proc Natl Acad Sci U S A (1987) 1.15
An antipeptide antibody that specifically inhibits insulin receptor autophosphorylation and protein kinase activity. Proc Natl Acad Sci U S A (1985) 1.11
The insulin receptor: structure and function. Crit Rev Biochem Mol Biol (1989) 1.08
The rat insulin receptor: primary structure and conservation of tissue-specific alternative messenger RNA splicing. Mol Endocrinol (1990) 1.05
Mapping surface structures of the human insulin receptor with monoclonal antibodies: localization of main immunogenic regions to the receptor kinase domain. Biochemistry (1986) 1.04
The insulin receptor. A multifunctional protein. Diabetes (1990) 1.04
The preparation and specificity of antibody to thyrotropin releasing hormone. Endocrinology (1972) 1.04
Solid-phase synthesis of a range of O-phosphorylated peptides by post-assembly phosphitylation and oxidation. Int J Pept Protein Res (1991) 1.04
Monoclonal antibodies to the insulin receptor stimulate the intrinsic tyrosine kinase activity by cross-linking receptor molecules. EMBO J (1987) 1.03
Conformational changes in the alpha- and beta-subunits of the insulin receptor identified by anti-peptide antibodies. J Biol Chem (1989) 1.03
Characterization of monoclonal antibodies directed against human thyroid stimulating hormone. J Immunol Methods (1982) 1.00
A 'dot-immunobinding assay' on nitrocellulose membrane for the determination of the immunoglobulin class of mouse monoclonal antibodies. J Immunol Methods (1984) 1.00
Identification of epitopes on the human insulin receptor reacting with rabbit polyclonal antisera and mouse monoclonal antibodies. J Biol Chem (1990) 0.98
Subcellular fractionation of tissue culture cells. Trends Biochem Sci (1989) 0.97
An improved sequencing method using Sequenase that is independent of template concentration. Nucleic Acids Res (1988) 0.97
The cysteine-rich domains of the insulin and insulin-like growth factor I receptors are primary determinants of hormone binding specificity. Evidence from receptor chimeras. J Biol Chem (1990) 0.97
Antibodies to deduced sequences of the insulin receptor distinguish conserved and nonconserved regions in the IGF-I receptor. J Biol Chem (1986) 0.94
Isolation of a proteolytically derived domain of the insulin receptor containing the major site of cross-linking/binding. Biochemistry (1989) 0.94
Characterization of two insulin-binding components of rat-liver plasma membranes. Biosci Rep (1982) 0.93
Changing the insulin receptor to possess insulin-like growth factor I ligand specificity. Biochemistry (1990) 0.92
Molecular basis of insulin receptor function. Br Med Bull (1989) 0.88
Identification of retinal insulin receptors using site-specific antibodies to a carboxyl-terminal peptide of the human insulin receptor alpha-subunit. Up-regulation of neuronal insulin receptors in diabetes. J Biol Chem (1990) 0.88
Insulin binding to its receptor induces a conformational change in the receptor C-terminus. Biochemistry (1990) 0.86
Identification of a phosphorylation site of the rat insulin receptor catalyzed by protein kinase C in an intact cell. FEBS Lett (1989) 0.83
Purification and characterization of the human brain insulin receptor. J Biol Chem (1986) 0.83
Evidence that insulin plus ATP may induce a conformational change in the beta subunit of the insulin receptor without inducing receptor autophosphorylation. J Biol Chem (1991) 0.83
Identification of the intact insulin receptor using a sequence-specific antibody directed against the C-terminus of the beta-subunit. Endocrinology (1987) 0.81
Insulin receptor antibodies. Methods Enzymol (1981) 0.80
Monoclonal antibodies to the insulin receptor. Pharmacol Ther (1985) 0.79
Antibodies to insulin receptor tyrosine kinase stimulate its activity towards exogenous substrates without inducing receptor autophosphorylation. Biochem J (1989) 0.78
Antipeptide antibodies toward the extracellular domain of insulin receptor beta-subunit. Biochem Biophys Res Commun (1989) 0.76
Construction of a new family of high efficiency bacterial expression vectors: identification of cDNA clones coding for human liver proteins. EMBO J (1984) 7.60
Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature (1997) 7.33
Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature (2000) 5.86
Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J (1988) 4.54
Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J (1998) 3.94
Identification, sequencing and expression of an integral membrane protein of the trans-Golgi network (TGN38). Biochem J (1990) 3.88
Enhanced expression of cro-beta-galactosidase fusion proteins under the control of the PR promoter of bacteriophage lambda. EMBO J (1982) 3.69
Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. Biochem J (1989) 3.34
Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity. Proc Natl Acad Sci U S A (1987) 2.99
TGN38 is maintained in the trans-Golgi network by a tyrosine-containing motif in the cytoplasmic domain. EMBO J (1993) 2.79
The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature (1989) 2.75
Solubilization and immune-detection of beta-galactosidase hybrid proteins carrying foreign antigenic determinants. Nucleic Acids Res (1983) 2.35
Efficient construction of cDNA libraries in plasmid expression vectors using an adaptor strategy. Nucleic Acids Res (1986) 2.28
Subcellular distribution and movement of 5'-nucleotidase in rat cells. Biochem J (1980) 2.20
The sequence and topology of human complement component C9. EMBO J (1985) 2.18
High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc Natl Acad Sci U S A (1992) 2.15
Immunoaffinity purification of human complement component C9 using monoclonal antibodies. J Immunol Methods (1983) 2.11
Regulation of caveolin and caveolae by cholesterol in MDCK cells. J Lipid Res (1998) 1.96
pUEX, a bacterial expression vector related to pEX with universal host specificity. Nucleic Acids Res (1987) 1.93
Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor. Biochem J (1986) 1.87
High throughput direct end sequencing of BAC clones. Nucleic Acids Res (1999) 1.85
Elevated plasma adiponectin in humans with genetically defective insulin receptors. J Clin Endocrinol Metab (2006) 1.71
Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis. Nature (1986) 1.70
Bronchiectasis. Third report on a follow-up study of medical and surgical cases from childhood. Arch Dis Child (1969) 1.67
Clathrin heavy chain, light chain interactions. EMBO J (1983) 1.67
Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling. Clin Cancer Res (1999) 1.63
Molecular cloning of S-protein, a link between complement, coagulation and cell-substrate adhesion. EMBO J (1985) 1.56
Toxoplasma antibodies in sera from Hong Kong. J Hyg (Lond) (1969) 1.53
Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells. Biochem J (1990) 1.49
Compartment-specific regulation of phosphoinositide 3-kinase by platelet-derived growth factor and insulin in 3T3-L1 adipocytes. Biochem J (1996) 1.49
c-Jun is a JNK-independent coactivator of the PU.1 transcription factor. J Biol Chem (1999) 1.49
Testicular cancer secretes intact human choriogonadotropin (hCG) and its free beta-subunit: evidence that hCG (+hCG-beta) assays are the most reliable in diagnosis and follow-up. Clin Chem (1990) 1.46
The insulin receptor tyrosyl kinase phosphorylates holomeric forms of the guanine nucleotide regulatory proteins Gi and Go. FEBS Lett (1987) 1.46
Solubilization and purification of rat liver 5'-nucleotidase by use of a zwitterionic detergent and a monoclonal-antibody immunoadsorbent. Biochem J (1982) 1.44
The subpopulations of circulating white blood cells in inflammatory bowel disease. Gastroenterology (1976) 1.41
All low density lipoprotein particles are partially desialylated in plasma. Atherosclerosis (1998) 1.40
Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochem J (1993) 1.37
Phenobarbitone therapy in neonatal hyperbilirubinaemia. Lancet (1969) 1.32
A mechanism for the insertion of complement component C9 into target membranes. Mol Immunol (1986) 1.30
Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies. J Clin Endocrinol Metab (2010) 1.29
A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity. J Biol Chem (1992) 1.27
Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting. Biochem J (1997) 1.26
Inhibitors of phosphoinositide 3-kinase block exocytosis but not endocytosis of transferrin receptors in 3T3-L1 adipocytes. Biochem Biophys Res Commun (1995) 1.25
The transcription factors Egr1 and Egr2 have opposing influences on adipocyte differentiation. Cell Death Differ (2009) 1.24
A method for the determination of glucose-6-phosphatase activity in rat liver with [U-14C]glucose 6-phosphate as substrate. Anal Biochem (1978) 1.24
Transdominant inhibition of tyrosine kinase activity in mutant insulin/insulin-like growth factor I hybrid receptors. Proc Natl Acad Sci U S A (1991) 1.21
Tumor necrosis factor-alpha induces apoptosis of human adipose cells. Diabetes (1997) 1.21
The isolation of endosome-derived vesicles from rat hepatocytes. Biochem J (1983) 1.20
Analysis of insulin-receptor phosphorylation sites in intact cells by two-dimensional phosphopeptide mapping. Biochem J (1988) 1.18
Two-site monoclonal antibody assays for human heart- and brain-type creatine kinase. Clin Chem (1984) 1.18
Signaling-competent receptor chimeras allow mapping of major insulin receptor binding domain determinants. J Biol Chem (1993) 1.17
Quantification of polyacrylamide gel bands by digital image processing. Anal Biochem (1983) 1.16
The role of intermediates in mitochondrial fatty acid oxidation. Biochem J (1975) 1.15
Programming of adipose tissue miR-483-3p and GDF-3 expression by maternal diet in type 2 diabetes. Cell Death Differ (2012) 1.14
The effects of glucagon and insulin on adenosine 3':5'-cyclic monophosphate concentrations in an organ culture of mature rat liver. Biochem J (1973) 1.13
Production and characterization of monoclonal antibodies to insulin secretory granule membranes. Biochem J (1987) 1.13
Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors. Biochem Soc Trans (2001) 1.11
The role of insulin receptor kinase domain autophosphorylation in receptor-mediated activities. Analysis with insulin and anti-receptor antibodies. J Biol Chem (1992) 1.11
Monoclonal antibodies to the insulin receptor mimic metabolic effects of insulin but do not stimulate receptor autophosphorylation in transfected NIH 3T3 fibroblasts. Proc Natl Acad Sci U S A (1989) 1.11
A new recombinant DNA strategy for the molecular cloning of rare membrane proteins. Biochem J (1990) 1.11
Insulin-like and insulin-inhibitory effects of monoclonal antibodies for different epitopes on the human insulin receptor. Biochem J (1987) 1.09
Immunoradiometric assay for human complement component C9 utilising monoclonal antibodies. Clin Chim Acta (1983) 1.08
c phosphorylation and activation of the IGF-I receptor in src-transformed cells. J Biol Chem (1994) 1.07
Plan of Treatment for Gastro-enteritis in Infants. Br Med J (1943) 1.06
cDNA cloning of granzyme C, a granule-associated serine protease of cytolytic T lymphocytes. J Immunol (1988) 1.06
Intracellular targetting signals of polymeric immunoglobulin receptors are highly conserved between species. FEBS Lett (1989) 1.05
The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta superfamily member, acts as a quality control determinant for correctly folded MIC-1. EMBO J (2000) 1.05
Identification of two epitopes in the carboxyterminal 15 amino acids of the E1 glycoprotein of mouse hepatitis virus A59 by using hybrid proteins. J Virol (1986) 1.03
Monoclonal antibodies to the insulin receptor stimulate the intrinsic tyrosine kinase activity by cross-linking receptor molecules. EMBO J (1987) 1.03
The existence and properties of two dimers of rat liver ecto-5'-nucleotidase. Biochem J (1984) 1.01
Defect in insulin-like growth factor-1 survival mechanism in atherosclerotic plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and signaling. Circ Res (2001) 1.01
Insulin-like growth factors in human breast cancer. Breast Cancer Res Treat (1998) 1.01
Involvement of phosphoinositide 3-kinase in insulin stimulation of MAP-kinase and phosphorylation of protein kinase-B in human skeletal muscle: implications for glucose metabolism. Diabetologia (1997) 1.01
A monoclonal antibody inhibiting rat liver 5'-nucleotidase. FEBS Lett (1981) 1.00
Hormonal control of adipose-tissue lipolysis. Biochem Soc Symp (1978) 1.00
The molecular mechanism of complement C9 insertion and polymerisation in biological membranes. Curr Top Microbiol Immunol (1989) 1.00
Characterization of monoclonal antibodies directed against human thyroid stimulating hormone. J Immunol Methods (1982) 1.00
Intermediates in fatty acid oxidation. Biochem J (1973) 1.00
Hypoketotic hypofattyacidaemic hypoinsulinaemic hypoglycaemia in a child with hemihypertrophy? A new syndrome. Horm Res (2004) 1.00
Localisation of 5'-nucleotidase in a rat liver cell line using a monoclonal antibody and indirect immunofluorescent labelling. Exp Cell Res (1983) 0.99
Immunolocalization of complement component C9 on necrotic and non-necrotic muscle fibres in myositis using monoclonal antibodies: a primary role of complement in autoimmune cell damage. Immunology (1984) 0.99
Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytes. J Biol Chem (1999) 0.98
Insulin receptor kinase domain autophosphorylation regulates receptor enzymatic function. J Biol Chem (1992) 0.98
Identification of epitopes on the human insulin receptor reacting with rabbit polyclonal antisera and mouse monoclonal antibodies. J Biol Chem (1990) 0.98
The occurrence of intermediates in mitochondrial fatty acid oxidation. FEBS Lett (1974) 0.98
Androgen receptor expression is greater in macrophages from male than from female donors. A sex difference with implications for atherogenesis. Circulation (2000) 0.98
Cytoplasmic juxtamembrane region of the insulin receptor: a critical role in ATP binding, endogenous substrate phosphorylation, and insulin-stimulated bioeffects in CHO cells. Biochemistry (1991) 0.98